Pax World Management Llc Upped Catalent Inc (NYSE:CTLT) Position as Price Declined by $10.74 Million

May 16, 2018 - By Jenna Rose

Catalent, Inc. (NYSE:CTLT) Corporate LogoDuring 2017 Q4 the big money sentiment decreased to 1.44. That’s change of 1.17, from 2017Q3’s 2.61. 37 investors sold all, 68 reduced holdings as CTLT ratio is negative. 110 rose stakes while 41 funds bought stakes. Funds hold 130.69 million shares thus 0.15% less from 2017Q3’s 130.89 million shares. State Teachers Retirement holds 0.01% or 77,200 shs. New York-based Blackrock has invested 0.03% in Catalent, Inc. (NYSE:CTLT). Parallax Volatility Advisers L P stated it has 0% of its capital in Catalent, Inc. (NYSE:CTLT). Moreover, Voya Mngmt Lc has 0.09% invested in Catalent, Inc. (NYSE:CTLT) for 1.09M shs. 355,755 are owned by Castleark Mgmt Ltd. Argent Cap Ltd Llc holds 0.02% of its capital in Catalent, Inc. (NYSE:CTLT) for 15,491 shs. Lpl Financial Limited Company stated it has 0% in Catalent, Inc. (NYSE:CTLT). Stratos Wealth Ltd invested in 0% or 142 shs. 9,318 were reported by Shelton Cap Mngmt. Colony Group Ltd Llc holds 0.27% or 104,495 shs in its capital. Regions Finance Corporation holds 7,520 shs. Bowling Ltd Liability Corp invested in 43,981 shs or 0.24% of the stock. 97,382 are held by State Board Of Administration Of Florida Retirement Sys. Bluemar Capital Management Limited Co has 1.54% invested in Catalent, Inc. (NYSE:CTLT). Pub Employees Retirement Association Of Colorado holds 0% or 16,119 shs in its capital.

CTLT registered $7.57 million net activity with 0 buys and 2 sales since December 11, 2017. Another trade for 181,458 shs valued at $7.19M was made by Chiminski John R on Monday, December 11.

Based on the latest 2018Q1 form from the SEC, Pax World Management Llc increased its stake in Catalent Inc (NYSE:CTLT) by 152.29%. Catalent Inc (NYSE:CTLT) stock Sank 4.27% while Pax World Management Llc bought 261,851 shares. It held 433,796 shares of Catalent Inc (NYSE:CTLT) at the end of 2018Q1, valued at $17.81 million, up from 171,945 last quarter. $5.25B is the MC of Catalent Inc. CTLT hit $39.38 during the last trading session after $0.13 change.Catalent, Inc. has volume of 506,354 shares. Since May 16, 2017 CTLT has risen 39.51% and is uptrending. CTLT outperformed by 27.96% the S&P 500.

Pax World Management Llc cut its stake in Cisco Sys Inc (NASDAQ:CSCO) and reduced Apple Inc (NASDAQ:AAPL) position by 102,500 shares for a total of 142,375 shares.

Pax World Management Llc is a New Hampshire-based institutional investor with more than $3.21 billion AUM in July, 2014. Taken from Pax World Management latest Adv, the fund reported to have 46 full and part-time employees. Among which 15 performing investment advisory and research functions. The institutional investor had between 11-25 clients.

Catalent, Inc. (NYSE:CTLT) Ratings Coverage

A total of 8 analysts rate Catalent (NYSE:CTLT) as follows: 5 “Buy”, 3 “Hold” and 0 “Sell”. Тherefore 63% are bullish. (NYSE:CTLT) has 9 ratings reports on 16 May 2018 according to StockzIntelligence. On Wednesday, March 28 the rating was upgraded by KeyBanc Capital Markets to “Overweight”. On Monday, February 5 the stock of Catalent, Inc. (NYSE:CTLT) earned “Hold” rating by Jefferies. On Monday, February 5 RBC Capital Markets maintained Catalent, Inc. (NYSE:CTLT) rating. RBC Capital Markets has “Buy” rating and $48.0 target. On Wednesday, March 21 the rating was upgraded by Raymond James to “Outperform”. On Tuesday, February 6 the company was maintained by Bank of America. On Tuesday, February 6 the stock of Catalent, Inc. (NYSE:CTLT) earned “Hold” rating by Stephens.

Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products worldwide.The company has $5.25 billion market cap. It operates through three divisions: Softgel Technologies, Drug Delivery Solutions, and Clinical Supply Services.71.86 is the P/E ratio. The Softgel Technologies segment offers formulation, development, and manufacturing services for softgels, which are used in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, and unit-dose cosmetics.

Catalent, Inc. (NYSE:CTLT) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.